Literature DB >> 15789147

Assessing outcome after a modified vaginal wall sling for stress incontinence with intrinsic sphincter deficiency.

Elisabetta Costantini1, Luigi Mearini, Ettore Mearini, Cinzia Pajoncini, Federico Guercini, Vittorio Bini, Massimo Porena.   

Abstract

Forty women with stress incontinence, intrinsic sphincter deficiency (ISD), associated or not with urethral hypermobility, a Valsalva leak point pressure (VLLP)<60 cmH(2)0 and a maximum urethral closure pressure<30 cmH(2)0 underwent in situ vaginal wall sling. The main modification to the technique was the use of two small Marlex meshes placed at the lateral edges of the sling. Outcome was assessed by pad use, surgical results and patients' satisfaction. Data of 39/40 patients were analyzed after a minimum follow-up of 1 year. After surgery 30/39 patients were completely dry (no pads), stress incontinence disappeared in 22/39, and 30/39 patients were satisfied with outcome. Reasons for dissatisfaction included recurrence of stress incontinence in three, infections in one and urge incontinence in five. Overall results are good given this category of patients. The vaginal wall sling can be recommended for patients with ISD because the results are promising, it corrects urethral hypermobility and, in our experience, it does not cause obstruction if correctly performed.

Entities:  

Mesh:

Year:  2004        PMID: 15789147     DOI: 10.1007/s00192-004-1173-5

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  26 in total

1.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

2.  Anatomical and functional results of pubovaginal sling procedure using polypropylene mesh for the treatment of stress urinary incontinence.

Authors:  H C Kuo
Journal:  J Urol       Date:  2001-07       Impact factor: 7.450

3.  Vaginal wall sling: four years later.

Authors:  S Juma; N A Little; S Raz
Journal:  Urology       Date:  1992-05       Impact factor: 2.649

4.  High failure rate using allograft fascia lata in pubovaginal sling surgery for female stress urinary incontinence.

Authors:  Y H Huang; A T Lin; K K Chen; C C Pan; L S Chang
Journal:  Urology       Date:  2001-12       Impact factor: 2.649

Review 5.  The in situ anterior vaginal wall sling: predictors of success.

Authors:  H B Goldman; R R Rackley; R A Appell
Journal:  J Urol       Date:  2001-12       Impact factor: 7.450

6.  Antimicrobial mesh versus vaginal wall sling: a comparative outcomes analysis.

Authors:  J M Choe; K Ogan; B S Battino
Journal:  J Urol       Date:  2000-06       Impact factor: 7.450

7.  Is modified in situ vaginal wall sling operation the treatment of choice for recurrent genuine stress incontinence?

Authors:  T H Su; J P Huang; Y L Wang; J M Yang; H J Wei; C L Huang
Journal:  J Urol       Date:  1999-12       Impact factor: 7.450

8.  Results of pubovaginal sling for the treatment of intrinsic sphincteric deficiency determined by questionnaire analysis.

Authors:  F Haab; B A Trockman; P E Zimmern; G E Leach
Journal:  J Urol       Date:  1997-11       Impact factor: 7.450

9.  Four-corner colposuspension: clinical and functional results.

Authors:  E Costantini; C Pajoncini; A Zucchi; R Lombi; V Bini; E Mearini; M Porena
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-02-12

10.  Clinical and urodynamic features of intrinsic sphincter deficiency.

Authors:  Cinzia Pajoncini; Elisabetta Costantini; Federico Guercini; Vittorio Bini; Massimo Porena
Journal:  Neurourol Urodyn       Date:  2003       Impact factor: 2.696

View more
  1 in total

1.  Could the vaginal wall sling still have a role after FDA's warning? the functional outcomes at 20 years.

Authors:  Ester Illiano; Francesco Trama; Alessandro Marchesi; Consuelo Fabi; Stefano Brancorsini; Elisabetta Costantini
Journal:  Ther Adv Urol       Date:  2022-03-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.